|
|
Progress in blood biomarkers to predict adverse cardiovascular events after myocardial infarction |
YAN Jingyi, CHEN Yequn |
|
|
Abstract Major adverse cardiovascular events(MACEs) after myocardial infarction(MI) decrease patients’ life quality and increase the risk of death. Timely detection of blood biomarkers can predict MACEs after MI which is beneficial for targeted prevention and treatment. This paper briefly reviews the progress in blood biomarkers to predict MACEs after MI. These blood biomarkers cover classic peripheral blood biomarkers including cardiac troponin, natriuretic peptide, Ddimer,high sensitivity C-reactive protein and copeptin, and the newly discovered protein and non-coding RNA over the past 20 years.
|
|
|
|
|
|
|
|